1782 related articles for article (PubMed ID: 28008784)
1. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
2. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
3. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
[TBL] [Abstract][Full Text] [Related]
4.
Mullish BH; Williams HR
Clin Med (Lond); 2018 Jun; 18(3):237-241. PubMed ID: 29858434
[TBL] [Abstract][Full Text] [Related]
5. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation in the treatment of Clostridium difficile infections.
Austin M; Mellow M; Tierney WM
Am J Med; 2014 Jun; 127(6):479-83. PubMed ID: 24582877
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Clostridium difficile infection and the microbiome.
Almeida R; Gerbaba T; Petrof EO
J Gastroenterol; 2016 Jan; 51(1):1-10. PubMed ID: 26153514
[TBL] [Abstract][Full Text] [Related]
8. Targeting Dysbiosis for the Treatment of Liver Disease.
Anand G; Zarrinpar A; Loomba R
Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
[TBL] [Abstract][Full Text] [Related]
9. Gut dysbacteriosis and intestinal disease: mechanism and treatment.
Meng X; Zhang G; Cao H; Yu D; Fang X; de Vos WM; Wu H
J Appl Microbiol; 2020 Oct; 129(4):787-805. PubMed ID: 32277534
[TBL] [Abstract][Full Text] [Related]
10. How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
Fuentes S; de Vos WM
Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356
[TBL] [Abstract][Full Text] [Related]
11. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
Peterson CT; Sharma V; Elmén L; Peterson SN
Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
[TBL] [Abstract][Full Text] [Related]
12. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
[TBL] [Abstract][Full Text] [Related]
13. Role of the microbiome, probiotics, and 'dysbiosis therapy' in critical illness.
Wischmeyer PE; McDonald D; Knight R
Curr Opin Crit Care; 2016 Aug; 22(4):347-53. PubMed ID: 27327243
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic administration and the development of obesity in children.
Principi N; Esposito S
Int J Antimicrob Agents; 2016 Mar; 47(3):171-7. PubMed ID: 26895606
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.
Vindigni SM; Broussard EK; Surawicz CM
Expert Rev Gastroenterol Hepatol; 2013 Sep; 7(7):615-28. PubMed ID: 24070153
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
Distrutti E; Monaldi L; Ricci P; Fiorucci S
World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
[TBL] [Abstract][Full Text] [Related]
18. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
19. Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?
Spinler JK; Ross CL; Savidge TC
Anaerobe; 2016 Oct; 41():51-57. PubMed ID: 27180657
[TBL] [Abstract][Full Text] [Related]
20. Microbiome Disturbances and Autism Spectrum Disorders.
Rosenfeld CS
Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
